Figure 5. Vascular endothelial growth
factor and bone morphogenetic protein-4 co-regulate angiogenesis. Human
umbilical vascular endothelial cells (HUVECs) and human diploid
fibroblasts were obtained (day 1) as cocultures in 24 well plates.
Medium, with treatments or vehicle, was replenished on days 1, 4, 7,
and 9. The assay was treated with vascular endothelial growth factor
(VEGF), Suramin, and recombinant human BMP-4. Tubule formation was
examined at day 11. Cells were fixed, quantitated, and visualized using
a combined ELISA and histology kit. A: Angiogenesis assay
demonstrating the combined effects of VEGF (pro-angiogenic) and BMP-4
(anti-angiogenic) on angiogenesis. Suramin was used as a negative
control. (magnification 10X). Representative images are shown. B:
Angiogenesis was quantitated by using anti-CD31 antibody coupled to a
soluble substrate, ρ-nitrophenol phosphate (ρ-NPP), which permits
quantitation by an optical density measurement. Data are expressed as
mean±SEM values. The asterisk indicates a significance at p<0.01 and
the double asterisk indicates a significance at p<0.001.